Aumet Raises $12M Series A Led by Emkan Capital

Why It Matters

The capital injection validates investor confidence in AI‑driven healthcare procurement and equips Aumet to address fragmented supply chains, potentially reshaping cost structures across the region’s health systems.

Key Takeaways

• Aumet raised $12M Series A led by Emkan Capital.
• Platform processes $1B GMV and over 5M transactions annually.
• AI procurement OS deployed in 32 hospitals and 500+ medical centers.
• Funding will fuel AI expansion, enterprise rollouts across GCC and beyond.
• Strategic investors include Qatar Development Bank, SABAH Fund, and AAIC.

Pulse Analysis

Aumet’s $12 million Series A, led by Saudi‑based Emkan Capital, marks a notable infusion of capital into the Middle East’s health‑tech ecosystem. The round, also backed by Qatar Development Bank, SABAH Fund and AAIC, underscores growing investor confidence in AI‑driven supply‑chain solutions for healthcare. Founded in 2016, Aumet has built an AI‑first procurement operating system that unifies inventory management, marketplace functions and predictive ordering for pharmacies and hospitals. The new funding is earmarked for expanding AI capabilities, accelerating enterprise deployments, and pushing the platform into new GCC and international markets.

The platform already commands a $1 billion gross merchandise value, processes more than five million transactions each year, and connects over 12,000 pharmacies with 1,000+ pharmaceutical suppliers across Jordan, Egypt and Saudi Arabia. Its enterprise tier is active in 32 hospitals, 500+ medical centers and 18 warehouses, a footprint that rivals early‑stage U.S. rivals such as Clarium. By consolidating fragmented procurement data, Aumet delivers cost savings and inventory efficiency, addressing a chronic pain point in emerging‑market health systems where manual ordering remains the norm.

Strategic participation from regional development banks and venture funds provides Aumet with both capital and policy leverage, facilitating collaborations with ministries of health and digital economy agencies. The company’s roadmap includes scaling its Pulse solution globally, deepening AI integration for chain and enterprise customers, and entering new markets beyond the GCC. If successful, Aumet could become the de‑facto operating system for healthcare supply chains in emerging economies, setting a template for AI‑centric procurement that larger, more mature markets may later adopt.

Deal Summary

Saudi Arabia-based healthtech Aumet announced the close of a $12 million Series A round, led by Emkan Capital and joined by Qatar Development Bank, SABAH Fund, AAIC, Shorooq Partners, Right Side Capital Management, Cigalah Group and Salehiya Trading Company. The funding will support AI expansion, enterprise deployments, and regional growth across the GCC and beyond.